Fireside chat with Dr Kim
https://pharmaust.com/wp-content/uploads/2022/12/Fireside-chat-with-Dr-Kim-edited.mp4
News & Announcements from PharmAust in 2022
PharmAust Canine Trial Update
PharmAust canine trial update (final) clarification
PharmAust Receives R&D Tax Incentive Refund
PharmAust Receives R&D Tax Incentive Refund
MND Trial Completes Enrolment of First Patient Cohort
MND Trial Completes Enrolment of First Patient Cohort (final)
PhamAust Webinar
https://pharmaust.com/wp-content/uploads/2022/11/PharmAust-Webinar.mp4
PhamAust AGM 2022
https://pharmaust.com/wp-content/uploads/2022/11/PharmAust-AGM-2022.mp4
PharmAust doses first patient with MPL in motor neurone disease trial
PharmAust doses first patient with MPL in motor neurone disease trial (External link)
PharmAust doses first patient in Phase 1/2 trial of monepantel treating Motor Neurone Disease
PharmAust doses first patient in Phase 1/2 trial of monepantel treating Motor Neurone Disease (External link)
PharmAust (ASX:PAA) doses first patient in MND trial
PharmAust (ASX:PAA) doses first patient in MND trial (External ink)
First Patient Dosed in MND Phase 1/2 Trial
First Patient Dosed in MND Phase 1-2 Trial